Cover Image

Editorial: Development/repurposing of drugs to tackle the multiple variants of SARS-CoV-2

Saved in:

Bibliographic Details
Main Author:	Dinorah Gambino (Author)
Format:	Book
Published:	Frontiers Media S.A., 2023-02-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

SARS-CoV-2: Virology and Drug Repurposing Approaches
by: Ratika Rahmasari, et al.
Published: (2020)

Rapamycin: Drug Repurposing in SARS-CoV-2 Infection
by: Jiri Patocka, et al.
Published: (2021)

Drug Repurposing for the Identification of Compounds with Anti-SARS-CoV-2 Capability via Multiple Targets
by: Pei-Chen Yu, et al.
Published: (2022)

Modeling of SARS-CoV-2 Treatment Effects for Informed Drug Repurposing
by: Charlotte Kern, et al.
Published: (2021)

Artificial intelligence-driven drug repurposing and structural biology for SARS-CoV-2
by: Kartikay Prasad, et al.
Published: (2021)

Anti-SARS‐CoV‐2 Repurposing Drug Database: Clinical Pharmacology Considerations
by: Xinyuan Zhang, et al.
Published: (2021)

Drug Repurposing Screen for Compounds Inhibiting the Cytopathic Effect of SARS-CoV-2
by: Catherine Z. Chen, et al.
Published: (2021)

New Approaches and Repurposed Antiviral Drugs for the Treatment of the SARS-CoV-2 Infection
by: Luana Vittoria Bauso, et al.
Published: (2021)

On the SARS-CoV-2 Variants
by: Fabio Scarpa, et al.
Published: (2024)

Repurposing Chloroquine Against Multiple Diseases With Special Attention to SARS-CoV-2 and Associated Toxicity
by: Siya Kamat, et al.
Published: (2021)

Drug Repurposing and Polypharmacology to Fight SARS-CoV-2 Through Inhibition of the Main Protease
by: Luca Pinzi, et al.
Published: (2021)

Synergistic anti-SARS-CoV-2 activity of repurposed anti-parasitic drug combinations
by: Kunlakanya Jitobaom, et al.
Published: (2022)

A review of SARS-CoV-2 drug repurposing: databases and machine learning models
by: Marim Elkashlan, et al.
Published: (2023)

In Silico Drug Repurposing of Penicillins to Target Main Protease Mpro of SARS-CoV-2
by: Baby Krishnaprasad, et al.
Published: (2020)

Repurposing of Four Drugs as Anti-SARS-CoV-2 Agents and Their Interactions with Protein Targets
by: Luis C. Vesga, et al.
Published: (2022)

Repurposing existing drugs: identification of SARS-CoV-2 3C-like protease inhibitors
by: Wei-Chung Chiou, et al.
Published: (2021)

Effectiveness of Drug Repurposing and Natural Products Against SARS-CoV-2: A Comprehensive Review
by: Velásquez PA, et al.
Published: (2024)

Identification of SARS-CoV-2 E Channel Blockers from a Repurposed Drug Library
by: Prabhat Pratap Singh Tomar, et al.
Published: (2021)

Computational and network pharmacology studies of Phyllanthus emblica to tackle SARS-CoV-2
by: Rupesh V. Chikhale, et al.
Published: (2021)

Decoding the next SARS-CoV-2 variant
by: Jeremy Nel, et al.
Published: (2022)

Lung disease network reveals impact of comorbidity on SARS-CoV-2 infection and opportunities of drug repurposing
by: Asim Bikas Das
Published: (2021)

Antiviral Activity of Repurposing Ivermectin against a Panel of 30 Clinical SARS-CoV-2 Strains Belonging to 14 Variants
by: Océane Delandre, et al.
Published: (2022)

Editorial: The Mechanisms of Action of Anti-SARS-CoV-2 Drugs
by: Wu Zhong, et al.
Published: (2022)

Editorial: SARS-CoV-2 in water
by: Eiji Haramoto, et al.
Published: (2022)

Risk management strategies and therapeutic modalities to tackle COVID-19/SARS-CoV-2
by: Syed Muhammad Ali Shah, et al.
Published: (2021)

Omicron variant in the current SARS-CoV-2 pandemic
by: Kaveh Nasiri, et al.
Published: (2022)

The Emergence and Spread of Novel SARS-CoV-2 Variants
by: Huaimin Yi, et al.
Published: (2021)

Immune Profile of SARS-CoV-2 Variants of Concern
by: Caterina A. M. La Porta, et al.
Published: (2021)

Repurposing of potential antiviral drugs against RNA-dependent RNA polymerase of SARS-CoV-2 by computational approach
by: Sivakumar Gangadharan, et al.
Published: (2022)

A Systematic Review of the Global Intervention for SARS-CoV-2 Combating: From Drugs Repurposing to Molnupiravir Approval
by: Ashour NA, et al.
Published: (2022)

The Anatomy of the SARS-CoV-2 Biomedical Literature: Introducing the CovidX Network Algorithm for Drug Repurposing Recommendation
by: Gates, Lyndsey Elaine, et al.
Published: (2020)

Repurposing of Plasminogen: An Orphan Medicinal Product Suitable for SARS-CoV-2 Inhalable Therapeutics
by: Anna Maria Piras, et al.
Published: (2020)

The Anti-Histamine Azelastine, Identified by Computational Drug Repurposing, Inhibits Infection by Major Variants of SARS-CoV-2 in Cell Cultures and Reconstituted Human Nasal Tissue
by: Robert Konrat, et al.
Published: (2022)

The coverage of SARS-CoV-2 vaccination and the willingness to receive the SARS-CoV-2 variant vaccine among employees in China
by: Xi-Ru Zhang, et al.
Published: (2023)

Drug repurposing screening validated by experimental assays identifies two clinical drugs targeting SARS-CoV-2 main protease
by: Denis N. Prada Gori, et al.
Published: (2023)

Corrigendum: Editorial: The mechanisms of action of anti-SARS-CoV-2 drugs
by: Wu Zhong, et al.
Published: (2022)

Strategies to tackle SARS-CoV-2 Mu, a newly classified variant of interest likely to resist currently available COVID-19 vaccines
by: Md. Jamal Hossain, et al.
Published: (2022)

Identification of Plitidepsin as Potent Inhibitor of SARS-CoV-2-Induced Cytopathic Effect After a Drug Repurposing Screen
by: Jordi Rodon, et al.
Published: (2021)

Drug Repurposing: Dipeptidyl Peptidase IV (DPP4) Inhibitors as Potential Agents to Treat SARS-CoV-2 (2019-nCoV) Infection
by: Praveen P. N. Rao, et al.
Published: (2021)

Vulnerabilities of the SARS-CoV-2 Virus to Proteotoxicity-Opportunity for Repurposed Chemotherapy of COVID-19 Infection
by: Maryam S. Al-Motawa, et al.
Published: (2020)